PR NEWSWIRE - Contenuti promozionali

CTA
immediapress comunicato stampa

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

SHANGHAI, April 9, 2026 /PRNewswire/ -- DualityBio ("DualityBio" or the "Company", Stock Code: 9606.HK) today announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", also known as DB-1303 or BNT323), has been acce...

immediapress comunicato stampa

METLEN Energy & Metals: Risultati Finanziari 2025

ATENE, Grecia e LONDRA, 9 aprile 2026 /PRNewswire/ -- METLEN Energy & Metals PLC (LSE Listing: MTLN, RIC: MTLN.L, Bloomberg: MTLN.LN |Athens Listing: MTLN, RIC: MTLNr.AT, Bloomberg: MTLN.GA, ADR: MYTHY US) annuncia oggi i risultati del 2025.

immediapress comunicato stampa

/C O R R E C T I O N -- KingstronBio/

In the news release, First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study, issued 08-Apr-2026 by KingstronBio over PR Newswire, please be advised the original version excluded an image during transmission by PR...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza